Gallus Biopharmaceuticals to Retain/Add 320 Jobs in Missouri
05/22/2011
Recently Gallus purchased the former 15-acre, 200,000-square-foot Centocor Biologics facility in Berkeley. The company plans to make an initial capital investment of $20 million to expand the facility, hire about 160 Centocor employees; and create about 160 new jobs over the next five years. The average salary is expected to be $88,500.
Gallus Biopharmaceuticals is a contract manufacturer of pharmaceuticals produced from cell cultures. It plans on expanding the commercially certified, FDA-approved facilities at the former Centocor plant by building a clinical services suite, expanding the existing development lab and fitting out a commercial suite.
The state of Missouri awarded Gallus a $14.6 million economic incentive package, redeemable over the next 10 years.
Project Announcements
AESC Expands Florence, South Carolina, Operations
03/28/2024
Alticor Expands Ada Township, Michigan, Operations
03/27/2024
Eastman Plans Longview, Texas, Production Operations
03/27/2024
DHL Supply Chain-Vantage Data Centers NV11 Plan Nevada Operations
03/26/2024
Big Jet Expands Pittsburgh, Pennsylvania, Operations
03/26/2024
Landmark Ceramics UST Expands Mt. Pleasant, Tennessee, Operations
03/25/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Logistics Analysis That Drives Industrial Site Selection
Q4 2023
-
Manufacturing Momentum Is Building
Q1 2024
-
Technology’s Influence on Workforce Development
Workforce Q4 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Industry in the Era of the Electron
Q1 2024